AIM Vaccine's mRNA-based Shingles Vaccine Receives FDA Approval for Clinical Study
CompanyDrug

AIM Vaccine’s mRNA-based Shingles Vaccine Receives FDA Approval for Clinical Study

NMPA Updates Rules on Domestic Production of Imported Medical Devices
Medical DevicePolicy / Regulatory

NMPA Updates Rules on Domestic Production of Imported Medical Devices

Broncus Medical's BroncQCT Approved by Zhejiang Administration for China Market Entry
CompanyMedical Device

Broncus Medical’s BroncQCT Approved by Zhejiang Administration for China Market Entry

Lifetech Scientific's LAmbre Plus LAA Closure System Gains US Medical Insurance Coverage
CompanyMedical Device

Lifetech Scientific’s LAmbre Plus LAA Closure System Gains US Medical Insurance Coverage

Hansoh Pharmaceutical Reports 21% Revenue Growth, Boosted by Innovative Drugs
Company

Hansoh Pharmaceutical Reports 21% Revenue Growth, Boosted by Innovative Drugs

Johnson & Johnson Pledges USD55 Billion for US Expansion, Focusing on Manufacturing and R&D
Company

Johnson & Johnson Pledges USD55 Billion for US Expansion, Focusing on Manufacturing and R&D

FDA Issues Second CRL to Hengrui's Camrelizumab Combo Due to Manufacturing Issues
CompanyDrug

FDA Issues Second CRL to Hengrui’s Camrelizumab Combo Due to Manufacturing Issues

AbbVie Sues Genmab Over Alleged Trade Secret Misappropriation in ADC Development
CompanyLegal / IP

AbbVie Sues Genmab Over Alleged Trade Secret Misappropriation in ADC Development

Shanghai Junshi Biosciences' Loqtorzi Approved for Hepatocellular Carcinoma Treatment
CompanyDrug

Shanghai Junshi Biosciences’ Loqtorzi Approved for Hepatocellular Carcinoma Treatment

Shanghai Pharmaceuticals Subsidiary Fined USD23 Million for Anti-Monopoly Violations
CompanyLegal / IP

Shanghai Pharmaceuticals Subsidiary Fined USD23 Million for Anti-Monopoly Violations

HutchMed's Tazverik Receives Conditional Approval from China's NMPA for Lymphoma Treatment
CompanyDrug

HutchMed’s Tazverik Receives Conditional Approval from China’s NMPA for Lymphoma Treatment

Shenzhen Kangtai Partners with AstraZeneca to Establish Vaccine JV in Beijing
CompanyDeals

Shenzhen Kangtai Partners with AstraZeneca to Establish Vaccine JV in Beijing